Answers are grounded in this paper and cite their sources.
Assesses diabetes risk screening in salon clients, suggesting an innovative prevention strategy.
Introduction and Objective: An estimated 80% of U.S. adults with prediabetes are unaware of their condition, limiting timely engagement in evidence-based diabetes prevention programs. Community-based screening approaches may reduce access barriers and strengthen referral pathways. The objective of our study was to assess the feasibility of a stylist-led diabetes risk screening and prevention referral intervention. Methods: A single group posttest study design was conducted with adult hair salon clients receiving services at least monthly. Participating stylists were licensed for at least 1 year. Feasibility outcomes included acceptability, implementation fidelity, and client provider follow up. Stylists administered the ADA/CDC Prediabetes Risk Test following a diabetes risk discussion and recommended that clients at high risk follow up with a healthcare provider or diabetes prevention program. Results: Of N=20 enrolled, 75% (n=15) of clients screened high risk for prediabetes; all were female, with 11 Black and 4 Latina participants. Most high-risk clients had a primary care provider and health insurance (n=14). Observations showed high fidelity among stylists (N=3) to risk discussions and screening protocols. Four clients returned provider follow up documentation. Reasons for non-follow up were limited access to providers during the study period or provider refusal to sign documentation due to recent normal glucose results. No participants enrolled in a Diabetes Prevention Program. Stylists reported high satisfaction and intent to continue screening but noted study-related data collection burden interfered with hair services. Conclusion: Hair salons are a feasible setting for diabetes risk screening. Future studies should prioritize streamlined community-clinic linkages and direct diabetes prevention program enrollment to improve follow up and risk reduction. Disclosure K.N. Palmer: None. R. Yurika: None. D. Marrero: Consultant; Current; Biolinq. T.R. Suero: None.
No takes yet. Share an insight, caveat, or question.
PALMER et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: